These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19389501)

  • 41. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
    Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
    Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supportive Care in Multiple Myeloma.
    Guzdar A; Costello C
    Curr Hematol Malig Rep; 2020 Apr; 15(2):56-61. PubMed ID: 32172361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic use of plasmapheresis in internal and skin diseases].
    Nenov D; Nenov K; Penev Z; Chankova P
    Vutr Boles; 1989; 28(4):129-31. PubMed ID: 2596085
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease.
    Ogata A; Kitano M; Hashimoto N; Iwasaki T; Hamano T; Kakishita E
    J Bone Miner Metab; 2002; 20(4):240-2. PubMed ID: 12115071
    [No Abstract]   [Full Text] [Related]  

  • 45. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India.
    Prakash J; Mandal AK; Vohra R; Wani IA; Hota JK; Raja R; Singh U
    Ren Fail; 2009; 31(4):267-71. PubMed ID: 19462274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Special Considerations for Supportive Care and Management of Complications in Elderly Patients With Multiple Myeloma.
    George LL; Malik MN; Miller EJ; Hicks K; Khanam R; Saterehaseman A; McNichol M; Anwer F
    Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):812-822. PubMed ID: 34384735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nephrologic complications in patients with multiple myeloma].
    Kes P
    Lijec Vjesn; 1984; 106(11-12):476-81. PubMed ID: 6521605
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multiple myeloma and the kidneys].
    Kamaeva OI
    Ter Arkh; 1997; 69(6):73-5. PubMed ID: 9297284
    [No Abstract]   [Full Text] [Related]  

  • 49. Myeloma--new approaches to combined nephrological-haematological management.
    Haubitz M; Peest D
    Nephrol Dial Transplant; 2006 Mar; 21(3):582-90. PubMed ID: 16396976
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of multiple myeloma bone disease: impact of treatment on renal function.
    Kanellias N; Gavriatopoulou M; Terpos E; Dimopoulos MA
    Expert Rev Hematol; 2018 Nov; 11(11):881-888. PubMed ID: 30285492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
    Dimopoulos MA; Pouli A; Anagnostopoulos A; Repoussis P; Symeonidis A; Terpos E; Delimbasi S; Tsolakis F; Economopoulos T; Zervas C
    Leuk Lymphoma; 2006 Aug; 47(8):1553-6. PubMed ID: 16966266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dickkopf-1: a suitable target for the management of myeloma bone disease.
    Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
    Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of renal complications in patients with advanced multiple myeloma.
    Viertel A; Weidmann E; Ditting T; Geiger H
    Leuk Lymphoma; 2000 Aug; 38(5-6):513-9. PubMed ID: 10953972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma cell neoplasia with osteosclerotic lesions. A study of five cases and a review of the literature.
    Driedger H; Pruzanski W
    Arch Intern Med; 1979 Aug; 139(8):892-6. PubMed ID: 223510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
    Nucci M; Anaissie E
    Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology and management of bone disease in multiple myeloma.
    Niesvizky R; Warrell RP
    Cancer Invest; 1997; 15(1):85-90. PubMed ID: 9028394
    [No Abstract]   [Full Text] [Related]  

  • 57. [Multiple bone myeloma].
    Arnulf B
    Rev Prat; 2013 Jan; 63(1):101-8. PubMed ID: 23457840
    [No Abstract]   [Full Text] [Related]  

  • 58. Complications of myeloma therapy.
    Dispenzieri A
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1247-73, xi. PubMed ID: 17996597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of renal dysfunction in the liver transplant recipient.
    Pham PT; Pham PC; Wilkinson AH
    Curr Opin Organ Transplant; 2009 Jun; 14(3):231-9. PubMed ID: 19395967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple myeloma presenting with an acute bacterial infection.
    Kalambokis GN; Christou L; Tsianos EV
    Int J Lab Hematol; 2009 Aug; 31(4):375-83. PubMed ID: 19486365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.